$714.86 Million in Sales Expected for Acadia Healthcare Company Inc (ACHC) This Quarter

Brokerages expect Acadia Healthcare Company Inc (NASDAQ:ACHC) to announce $714.86 million in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for Acadia Healthcare’s earnings. The lowest sales estimate is $708.90 million and the highest is $728.82 million. Acadia Healthcare reported sales of $702.89 million in the same quarter last year, which indicates a positive year-over-year growth rate of 1.7%. The business is scheduled to issue its next earnings results on Thursday, February 22nd.

On average, analysts expect that Acadia Healthcare will report full year sales of $714.86 million for the current fiscal year, with estimates ranging from $2.82 billion to $2.87 billion. For the next fiscal year, analysts expect that the company will report sales of $3.01 billion per share, with estimates ranging from $2.99 billion to $3.06 billion. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Acadia Healthcare.

ACHC has been the topic of several recent analyst reports. Jefferies Group set a $60.00 target price on shares of Acadia Healthcare and gave the stock a “buy” rating in a report on Wednesday, October 11th. Citigroup cut their target price on shares of Acadia Healthcare from $61.00 to $44.00 and set a “buy” rating on the stock in a report on Wednesday, October 25th. Cantor Fitzgerald cut their target price on shares of Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating on the stock in a report on Tuesday, October 24th. Deutsche Bank cut shares of Acadia Healthcare from a “buy” rating to a “hold” rating and cut their target price for the stock from $60.00 to $37.00 in a report on Wednesday, October 25th. Finally, Wells Fargo & Co initiated coverage on shares of Acadia Healthcare in a report on Tuesday, January 30th. They issued an “outperform” rating and a $41.00 target price on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $43.92.

In related news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Hedge funds have recently made changes to their positions in the stock. C M Bidwell & Associates Ltd. purchased a new stake in Acadia Healthcare in the second quarter worth $205,000. State of Alaska Department of Revenue purchased a new stake in Acadia Healthcare in the fourth quarter worth $150,000. Rathbone Brothers plc purchased a new stake in Acadia Healthcare in the third quarter worth $223,000. Shelton Capital Management purchased a new stake in Acadia Healthcare in the second quarter worth $289,000. Finally, Arthur Zaske & Associates LLC purchased a new stake in Acadia Healthcare in the third quarter worth $283,000.

Acadia Healthcare (NASDAQ ACHC) opened at $34.26 on Wednesday. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34. The stock has a market cap of $3,040.61, a P/E ratio of 17.39, a PEG ratio of 1.17 and a beta of 0.85.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/07/714-86-million-in-sales-expected-for-acadia-healthcare-company-inc-achc-this-quarter.html.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply